Executive Chairman Dr. Tan Kok Heng also increased his direct interest in the Company through a market acquisition of ordinary shares on 31 August 2026.

Dr. Tan acquired 30,000 ordinary shares at S$0.330 per share, representing a total consideration of approximately S$9,900. 

Following the transaction, Dr. Tan’s direct interest increased from 215,800 shares to 245,800 shares, representing approximately 0.14% of Lincotrade’s issued share capital. 

Chief Executive Officer, Mr. Soh Loong Chow Jackie increased his direct interest in Lincotrade & Associates Holdings Limited through a market acquisition of ordinary shares on 31 August 2026.

Mr. Soh acquired 83,300 ordinary shares at S$0.33246 per share, representing an estimated total consideration of approximately S$27,694. 

Following the transaction, Mr. Soh’s direct interest increased from 45,454,545 shares to 45,537,845 shares, representing approximately 25.17% of Lincotrade’s issued share capital. 

In aggregate, the two directors acquired 113,300 Lincotrade shares for approximately S$37,594 through market transactions.

See link for full media release: https://www.lincotrade.com.sg/announcements-overview/